$8.7M
The funding round will support the development of hospital-ready diagnostic products and broaden clinical access to glycan testing.
GlycanAge
GlycanAge develops glycan biomarker diagnostics to measure biological ageing and chronic inflammation.
$12.0MTotal raised
London-based biotechnology startup developing glycan biomarker diagnostics to measure biological ageing and track chronic inflammation.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Cash, assets and headcount from GlycanAge's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Founders
Gordan Lauc
CSO
Gordan serves as chief scientific officer of GlycanAge and chief executive of Genos, alongside academic posts at the University of Zagreb and King's College London. He brings extensive biochemical and academic experience to his ventures.
LinkedIn
Nikolina Lauc
CEO
Nikolina is the chief executive and co-founder of GlycanAge. She previously co-founded Lime Street and Raggedy.
LinkedInInvestors
- $8.7M
- £3.3MLLAUNCHubLeadKadmos CapitalLead
Funding history
£3.3M
The financing round was led by LAUNCHub Ventures and Kadmos Capital to fund the company's shift towards the diagnostics market.